Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients with Stage I-III Cutaneous Melanoma . (2024). SKIN The Journal of Cutaneous Medicine, 8(2), s386. https://doi.org/10.25251/skin.8.supp.386